Moderna will begin the Phase III trial of its coronavirus vaccine next month—a testament to the power of science, and the need for policy that helps it thrive.
First, the news: Dr. Anthony Fauci confirmed Moderna (BIO member!) will begin the Phase III trial of its COVID-19 vaccine in July, enrolling 30,000 individuals around the world in the randomized placebo trial, reports Forbes.
It’s not a done deal quite yet—but Phase III is “considered the final stage before potential approval by the U.S. Food and Drug Administration, which would make it available for patients across the country,” explains Forbes.
But it’s close enough that manufacturing is starting now, too. “We may know whether it’s efficacious by November or December. By that time, we hopefully would have close to 100 million [doses],” said Dr. Fauci in the conversation with JAMA.
This is the kind of big science we need. “[W]e need to do exactly what we've been doing, which is forget about borders. Forget about distinctions. Forget about small companies, large companies, academia, federally funded, private-funded, and all get together and collaborate and find new ways to approach this and take as many options, as many approaches as we can,” BIO President and CEO Dr. Michelle McMurry-Heath told The Hill’s Steve Clemons in an interview.
“Science has the ability to solve the most pressing issues that we face today,”she continued. “And making that science, making sure that that science gets done, that the innovators have the space to create and get their creations out to the patients and people who need them, that is a social justice fight that I am willing to fight and that I think we can win.”
Click to watch: